Scientific Review Questions New Alzheimer's Drug Efficacy

A recent scientific review has raised doubts about the effectiveness of new Alzheimer's medications, sparking a debate among experts over their limited impact on dementia progression.

16 Apr, 00:05 — 16 Apr, 00:05

Post Share

Sources

Showing 1 of 2 sources

NYTMostly Factual1h ago

Analysis of Alzheimer’s Drugs Stirs Debate About Their Effectiveness

The review said a certain class of drugs had little clinical benefit, but many Alzheimer’s experts criticized the analysis, saying it unfairly lumped failed drugs with two recently approved treatments.

By Pam Belluck

Read full article →

Coverage Timeline

First report: NYT · 16 Apr, 00:05|Full coverage: 2 · 1m|Window: 1m

NYT16 Apr, 00:05First to report

Analysis of Alzheimer’s Drugs Stirs Debate About Their Effectiveness

el-mundo16 Apr, 00:06Latest update

PERSPECTA

PERSPECTA

Scientific Review Questions New Alzheimer's Drug Efficacy

Sources

Analysis of Alzheimer’s Drugs Stirs Debate About Their Effectiveness

Coverage Timeline

Analysis of Alzheimer’s Drugs Stirs Debate About Their Effectiveness

Una revisión científica pone en duda los nuevos medicamentos contra el alzhéimer por su escaso impacto en el curso de la demencia

Related Stories

'Astronauts back on Earth': Artemis II crew splashes down after record-breaking moon flyby – video

Crucial Atlantic Ocean Current Closer to Collapse Than Expected

Review Finds New Alzheimer's Drugs Offer Minimal Benefit, Pose Risks

Study Highlights Risks and Limited Benefits of New Alzheimer's Medications

PERSPECTA